Cheryl R. Blanchard - 21 Jun 2023 Form 4 Insider Report for Dare Bioscience, Inc. (DARE)

Reporting relationship: Director
Issuer ticker: DARE
Reported as of: 21 Jun 2023
Net transaction value: $0
SEC form: 4
Accepted by SEC: 21 Jun 2023, 21:48:21 UTC
Prior SEC filing: 09 Jun 2023
Next SEC filing: 05 Mar 2024
Source filing: View source filing
Reporting owner signature: /s/Lisa Walters-Hoffert, Attorney-in-fact

Key filing fact

Cheryl R. Blanchard filed Form 4 for Dare Bioscience, Inc. (DARE) on 21 Jun 2023.

Key facts

This page summarizes Cheryl R. Blanchard's Form 4 filing for Dare Bioscience, Inc. (DARE).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 21 Jun 2023, 21:48.

Change

Previous filing in this sequence was filed on 09 Jun 2023.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

DARE transaction Derivative

Stock Option (right to buy)

Award

Transaction value: $0
Shares: +40,000
Change %
Price: $0.000000
Shares after: 40,000
Date: 21 Jun 2023
Ownership: Direct
Underlying class: Common stock
Underlying amount: 40,000
Exercise price: $0.9600
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

This option will vest in full on the earlier of the first anniversary of the grant date or immediately prior to the issuer's first annual meeting of stockholders occurring after the grant date, subject to the director's continued service as a director, and will become exercisable in full upon a change in control of the issuer.